Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
[2] [3] It belongs to a novel class of agents known as triple hormone receptor agonists , meaning it simultaneously activates three distinct receptors involved in appetite regulation and energy metabolism: GLP-1 (glucagon-like peptide-1) receptor reduces appetite and slows gastric emptying GIP (glucose-dependent insulinotropic polypeptide) receptor enhances insulin secretion and, based on preclinical and early clinical evidence, may contribute to improved fat metabolism Glucagon receptor preclinical and early clinical data suggest activation of this receptor may increase energy expenditure and promote fat breakdown (lipolysis), though the precise contribution in humans is still being characterised This triple-action mechanism distinguishes retatrutide from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) and tirzepatide (a dual GIP/GLP-1 receptor agonist)
Skin exposure can cause irritation, contact dermatitis, or allergic reactions, especially with plant extracts and adhesives, and manufacturing quality varies widely across wellness products
This is manageable but requires attention
A treatment that moves too quickly, causes significant side effects or leads to poor nutrition intake may not be sustainable
Keep in mind it comes as a 30 mL multi-use vial, should not be used in newborns, and should not be injected intravenously by itself due to its hypotonicity
